Literature DB >> 8547208

Is contractility depressed in the failing human heart?

J K Gwathmey1, R Liao, P A Helm, G Thaiyananthan, R J Hajjar.   

Abstract

Is contractility depressed in the failing human heart? The question must be approached in a stringent manner. Myocardium from failing human hearts has been shown to generate normal physiological force under the ideal conditions of low stimulation and an adequate energy supply. Nevertheless, even when subjected to physiologically conducive conditions, failing myocardium experiences a slowed relaxation, adversely affecting the diastolic properties of the heart. In addition, experiments have shown that increasing the contraction rates of failing hearts clearly results in lowered force and pressure evolution. This information indicates a decrease in contractile reserve in both a systolic and diastolic sense. Not surprisingly, the term end-stage heart failure becomes questionable when applied to myocardium obtained from patients undergoing cardiac transplantation. A number of studies involve such myocardium from feasible regions of the heart perfused within ideal physiological conditions yielding, at times, nonfailing performance. Therefore, it becomes imperative to bear in mind the role of such myocardium within the framework of the entire diseased heart.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547208     DOI: 10.1007/bf00878090

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  35 in total

1.  Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.

Authors:  M Böhm; I Morano; B Pieske; J C Rüegg; M Wankerl; R Zimmermann; E Erdmann
Journal:  Circ Res       Date:  1991-03       Impact factor: 17.367

2.  Post-extrasystolic potentiation and the force-frequency relationship: differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure.

Authors:  P J Phillips; J K Gwathmey; M D Feldman; F J Schoen; W Grossman; J P Morgan
Journal:  J Mol Cell Cardiol       Date:  1990-01       Impact factor: 5.000

3.  Phospholamban-mediated stimulation of Ca2+ uptake in sarcoplasmic reticulum from normal and failing hearts.

Authors:  M A Movsesian; J Colyer; J H Wang; J Krall
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

4.  Force-frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure.

Authors:  M Böhm; K La Rosée; U Schmidt; C Schulz; R H Schwinger; E Erdmann
Journal:  Clin Investig       Date:  1992-05

5.  Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle.

Authors:  P A Anderson; N N Malouf; A E Oakeley; E D Pagani; P D Allen
Journal:  Circ Res       Date:  1991-11       Impact factor: 17.367

6.  Calcium-activated force in a turkey model of spontaneous dilated cardiomyopathy: adaptive changes in thin myofilament Ca2+ regulation with resultant implications on contractile performance.

Authors:  J K Gwathmey; R J Hajjar
Journal:  J Mol Cell Cardiol       Date:  1992-12       Impact factor: 5.000

7.  Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium.

Authors:  J K Gwathmey; M T Slawsky; R J Hajjar; G M Briggs; J P Morgan
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

8.  Intracellular calcium transient of working human myocardium of seven patients transplanted for congestive heart failure.

Authors:  C F Vahl; A Bonz; T Timek; S Hagl
Journal:  Circ Res       Date:  1994-05       Impact factor: 17.367

9.  Contractile properties and Ca2+ release activity of the sarcoplasmic reticulum in dilated cardiomyopathy.

Authors:  A D'Agnolo; G B Luciani; A Mazzucco; V Gallucci; G Salviati
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

10.  Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.

Authors:  D J Beuckelmann; M Näbauer; E Erdmann
Journal:  Circulation       Date:  1992-03       Impact factor: 29.690

View more
  3 in total

1.  Arginine-glycine-aspartic acid (RGD)-containing peptides inhibit the force production of mouse papillary muscle bundles via alpha 5 beta 1 integrin.

Authors:  Vandana Sarin; Robert D Gaffin; Gerald A Meininger; Mariappan Muthuchamy
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

Review 2.  Phenotyping cardiomyopathy in adult zebrafish.

Authors:  Alexey V Dvornikov; Pieter P de Tombe; Xiaolei Xu
Journal:  Prog Biophys Mol Biol       Date:  2018-05-30       Impact factor: 3.667

Review 3.  Calcium and Heart Failure: How Did We Get Here and Where Are We Going?

Authors:  Natthaphat Siri-Angkul; Behzad Dadfar; Riya Jaleel; Jazna Naushad; Jaseela Parambathazhath; Angelia A Doye; Lai-Hua Xie; Judith K Gwathmey
Journal:  Int J Mol Sci       Date:  2021-07-09       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.